Joel Greenblatt Anavex Life Sciences Corp. Transaction History

Gotham Asset Management, LLC

  • $9.41 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$8.9 - $12.86 $20,986 - $30,323
2,358 Added 16.36%
16,775 $173,000
Q2 2022

Aug 15, 2022
BUY
$7.31 - $12.84 $105,388 - $185,114
14,417 New
14,417 $144,000
Q1 2022

May 16, 2022
SELL
$9.74 - $17.69 $172,534 - $313,360
-17,714 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$16.88 - $23.31 $299,012 - $412,913
17,714 New
17,714 $307,000

Others Institutions Holding AVXL

# of Institutions
155
Shares Held
27.3M
Call Options Held
515K
Put Options Held
838K
View Full List

About ANAVEX LIFE SCIENCES CORP.

AVXL Quotes by TradingView
  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $673M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email